We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current BFRIW market cap is 61.56k. The company's latest EPS is USD -14.7156 and P/E is -0.07.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 10.14M | 8.93M | 5.85M | 8.9M | 10.6M |
| Operating Income | -5.32M | -5.49M | -8.6M | -4.42M | -3.87M |
| Net Income | -2.79M | -7.48M | -9.84M | -6.34M | 3.53M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 18.85M | 24.1M | 28.67M | 34.07M |
| Operating Income | -9.61M | -26.6M | -22.38M | -22.58M |
| Net Income | -10.99M | -37.71M | -640k | -20.13M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 50.88M | 41.97M | 36.91M | 34.1M | 27.93M |
| Total Liabilities | 27.01M | 25.21M | 29.73M | 33.07M | 23.14M |
| Total Equity | 23.88M | 16.75M | 7.17M | 1.04M | 4.79M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 24.14M | 53.22M | 50.88M | 27.93M |
| Total Liabilities | 18.31M | 41.88M | 27.01M | 23.14M |
| Total Equity | 5.83M | 11.34M | 23.88M | 4.79M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -16.2M | -3.69M | -14.03M | -16.03M | -24.9M |
| Investing | -5.16M | -14k | 164k | 546k | 619k |
| Financing | 14.02M | N/A | 1.11M | 1.7M | 8.41M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.37M | -26.72M | -16.2M | -24.9M |
| Investing | N/A | -11k | -5.16M | 619k |
| Financing | 13.19M | 43.19M | 14.02M | 8.41M |
| Market Cap | 61.56k |
| Price to Earnings Ratio | -0.07 |
| Price to Sales Ratio | 0.04 |
| Price to Cash Ratio | 1.05 |
| Price to Book Ratio | 0.29 |
| Dividend Yield | - |
| Shares Outstanding | 1.37M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.04 (46.67%) |
| Company Name | Biofrontera Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.biofrontera-us.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
